Journal of Pharmaceutical Research International

Aim: To investigate pathological conditions of COVID-19 individuals having type 1 diabetes throughout hospitalization and home isolation.

Methods: This retrospective analysis included 32 COVID-19 in addition T1D individuals who sought therapy at Services Hospital, Lahore, between May 1, 2021, and July 30, 2021. Patient information was obtained from electronic medical records.

Results: 23.8 percent of 32 COVID-19 individuals having T1D needed hospitalization, whereas 78.1 percent needed home isolation. 10.6 percent (4/35) of the study group had hypertension, 23.7 percent (8/34) had chronic pulmonary disease (CPD), 17.9 percent (7/35) had thyroid abnormalities, and 19.9 percent (7/37) had celiac disease. Of the 36 individuals tested, 66.9 percent (21/37) were classified as normal, 29.3 percent (10/36) as having serious kidney illness (CKD) II, and 4.3 percent (2/37) as having end-stage renal failure. The most facing health reported amongst hospitalized individuals remained nausea and vomiting (72.5 percent; 5/7), fever (57.1 percent; 4/7), cough (42.8 percent; 3/7), sore throat (42.8 percent; 3/7), stomach discomfort (42.8 percent; 3/7), and dyspnea (42. percent; 3/7). Diabetic ketoacidosis (71.4 percent; 5/7) was the most prevalent cause for hospitalization, followed by bacterial pneumonia (14.3 percent; 1/7), fever (14.3 percent; 1/7), sore throat (14.3 percent; 1/7), severe hyperglycemia (14.3 percent; 1/7), and COVID-19 pneumonia (14.3 percent; 1/7). Excluding for harshness of COVID-19 (p 14 0.0001), no demographic or medical indicators revealed statistically substantial changes between patients needing hospitalization also those who could be isolated at home.

Conclusion: The popular of COVID-19 T1D individuals healed at home without conservative treatment. The most prevalent cause for admission was diabetic ketoacidosis.